Skip to content

Mankind Pharma IPO shares trade with single-digit premium in grey market

Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22.

Read More

​ Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22. Mankind Pharma is focused largely on the domestic market, which contributed to 97.60 percent to its revenue from operations for FY22.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish